SCHEMBL18650697

C=CCOC1O[C@H](CO[C@@H]2O[C@H](CO[C@@H]3O[C@H](CO)[C@@H](C)[C@H](C)[C@H]3OC(=O)c3ccccc3)[C@@H](OC(=O)c3ccccc3)[C@H](OC(=O)c3ccccc3)[C@H]2OC(=O)c2ccccc2)[C@@H](OC(=O)c2ccccc2)[C@H](OC(=O)c2ccccc2)[C@H]1OC(=O)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 11)

	gene	UniProt	supporting neighbours	confidence
▸	LGALS3	P17931	2/20	0.41

▸	LGALS9	O00182	1/20	0.41

▸	LGALS1	P09382	1/20	0.41

▸	LGALS7; LGALS7B	P47929	1/20	0.41

▸	SELP	P16109	7/20	0.38

▸	PTPN1	P18031	10/20	0.38

▸	SELE	P16581	1/20	0.37

▸	LGALS4	P56470	1/20	0.37

▸	PTPN2	P17706	2/20	0.36

▸	PTPN6	P29350	2/20	0.36

▸	PTPN11	Q06124	2/20	0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL18650711	0.92	PTPN1 (0.38)	LGALS3LGALS9LGALS1LGALS7; LGALS7BPTPN1
SCHEMBL18654198	0.92	LGALS3 (0.45)	LGALS3LGALS9LGALS1LGALS7; LGALS7BSELP
SCHEMBL18654204	0.92	LGALS3 (0.45)	LGALS3LGALS9LGALS1LGALS7; LGALS7BSELP
SCHEMBL20226195	0.91	PTPN1 (0.44)	PTPN1PTPN2PTPN11
SCHEMBL20226188	0.91	PTPN1 (0.44)	PTPN1PTPN2PTPN11
SCHEMBL18650710	0.91	LGALS3 (0.43)	LGALS3LGALS9LGALS1LGALS7; LGALS7BSELP
SCHEMBL20226186	0.88	LGALS3 (0.48)	LGALS3LGALS9LGALS1LGALS7; LGALS7BSELP
SCHEMBL17241861	0.88	LGALS3 (0.48)	LGALS3LGALS9LGALS1LGALS7; LGALS7BSELP
SCHEMBL17241860	0.88	LGALS3 (0.48)	LGALS3LGALS9LGALS1LGALS7; LGALS7BSELP
SCHEMBL2483143	0.88	LGALS3 (0.48)	LGALS3LGALS9LGALS1LGALS7; LGALS7BSELP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20170081428-A1	IMMUNOMODULATING BETA-1,6-D-GLUCANS	INNATE BIOTHERAPEUTICS, LLC	2017-03-23	—	—	US	disclosed